Final Outcomes of Escalated Melphalan 280 mg/m2 Prior to Autologous Hematopoietic Cell Transplantation for Multiple Myeloma (MM): High CR+VGPR Rate Does Not Translate Into Improved Survival

Saved in:
Bibliographic Details
Published inBiology of blood and marrow transplantation Vol. 19; no. 2; pp. S132 - S133
Main Authors Randhawa, Jasleen K, Hari, Parameswaran N, Reece, Donna E, Vesole, David
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.02.2013
Subjects
Hematology, Oncology and Palliative Medicine
Online AccessGet full text

Cover

More Information
ISSN:1083-8791
1523-6536
DOI:10.1016/j.bbmt.2012.11.068